Unknown

Dataset Information

0

Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.


ABSTRACT: BACKGROUND:Common genetic variants residing near upstream regulatory elements for MYB, the gene encoding transcription factor cMYB, promote the persistence of fetal hemoglobin (HbF) into adulthood. While they have no consequences in healthy individuals, high HbF levels have major clinical benefits in patients with sickle cell disease (SCD) or ? thalassemia. Here, we present our detailed investigation of HBS1L-MYB intergenic polymorphism block 2 (HMIP-2), the central component of the complex quantitative-trait locus upstream of MYB, in 1,022 individuals with SCD in Tanzania. METHODS:We have looked at 1022 individuals with HbSS or HbS/?(0) in Tanzania. In order to achieve a detailed analysis of HMIP-2, we performed targeted genotyping for a total of 10 SNPs and extracted additional 528 SNPs information from a genome wide scan involving the same population. Using MACH, we utilized the existing YRI data from 1000 genomes to impute 54 SNPs situated within HIMP-2. RESULTS:Seven HbF-increasing, low-frequency variants (??>?0.3, p?

SUBMITTER: Mtatiro SN 

PROVIDER: S-EPMC4422446 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Genetic association of fetal-hemoglobin levels in individuals with sickle cell disease in Tanzania maps to conserved regulatory elements within the MYB core enhancer.

Mtatiro Siana N SN   Mgaya Josephine J   Singh Tarjinder T   Mariki Harvest H   Rooks Helen H   Soka Deogratius D   Mmbando Bruno B   Thein Swee Lay SL   Barrett Jeffrey C JC   Makani Julie J   Cox Sharon E SE   Menzel Stephan S  

BMC medical genetics 20150210


<h4>Background</h4>Common genetic variants residing near upstream regulatory elements for MYB, the gene encoding transcription factor cMYB, promote the persistence of fetal hemoglobin (HbF) into adulthood. While they have no consequences in healthy individuals, high HbF levels have major clinical benefits in patients with sickle cell disease (SCD) or β thalassemia. Here, we present our detailed investigation of HBS1L-MYB intergenic polymorphism block 2 (HMIP-2), the central component of the comp  ...[more]

Similar Datasets

| S-EPMC4341902 | biostudies-literature
| S-EPMC4221031 | biostudies-literature
| EGAS00001000990 | EGA
| S-EPMC3139383 | biostudies-literature
| S-EPMC7685210 | biostudies-literature
| S-EPMC3973089 | biostudies-literature
| S-EPMC7275552 | biostudies-literature
| S-EPMC3302931 | biostudies-literature
| S-EPMC7700170 | biostudies-literature
| S-EPMC2491485 | biostudies-literature